12:00 AM
Jan 07, 2013
 |  BC Week In Review  |  Company News  |  Other News

Acadia Pharmaceuticals, Axxam, Vicore Pharma, Merck KGaA, National Multiple Sclerosis Society autoimmune news

Merck's EMD Serono Inc. subsidiary and the society's not-for-profit Fast Forward LLC subsidiary awarded over $1.4 million to three programs for early stage drug discovery research to treat multiple sclerosis. Acadia will receive $545,380 over 12 months...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >